Myeloproliferative neoplasm: Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Myeloproliferative neoplasm}} | {{Myeloproliferative neoplasm}} | ||
{{CMG}} | {{CMG}} | ||
{{SK}} | {{SK}} MPN, myeloproliferative disease, myeloproliferative disorder, myeloproliferation | ||
==[[Myeloproliferative neoplasm overview|Overview]]== | ==[[Myeloproliferative neoplasm overview|Overview]]== | ||
Revision as of 14:07, 2 April 2015
|
Myeloproliferative Neoplasm Microchapters |
|
Differentiating myeloproliferative neoplasm from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Myeloproliferative neoplasm On the Web |
|
American Roentgen Ray Society Images of Myeloproliferative neoplasm |
|
Directions to Hospitals Treating Myeloproliferative neoplasm |
|
Risk calculators and risk factors for Myeloproliferative neoplasm |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: MPN, myeloproliferative disease, myeloproliferative disorder, myeloproliferation
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating myeloproliferative neoplasm from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Chest X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies